Skip to main content
Warning Date
    2007-07-29

Neem Active Toothpaste with Calcium in Canada found to contain diethylene glycol

2007-07-29

Health Canada is warning Canadians not to use Neem Active Toothpaste with Calcium, manufactured by Calcutta Chemical Co. Ltd. in India and found on the Canadian market, because it has been found to contain unacceptable levels of diethylene glycol (DEG).

  • To report sector-related issues

  • Call Centre 19999


Other Warnings

Warning Date
    2007-07-29

Health Canada warns consumers not to use Zencore Tabs due to potential health risks

2007-07-29

Health Canada is warning consumers not to use Zencore Tabs, a product advertised as a dietary supplement for sexual enhancement, because it contains an undeclared pharmaceutical ingredient similar to the approved drug tadalafil. Tadalafil is a prescription medication indicated for the treatment of erectile dysfunction and should only be used under the supervision of a health professional.

  • To report sector-related issues

  • Call Centre 19999


Other Warnings

Warning Date
    2007-07-29

Health Canada advises consumers not to use Liviro3 dietary supplement due to potential health risks

2007-07-29

Health Canada is advising consumers not to use Liviro3, a natural health product marketed for sexual enhancement, due to concerns about possible side-effects. The product is not authorized for sale in Canada and has not been found in the Canadian marketplace, but is for sale on the Internet, and may have been brought into the country by travellers.

  • To report sector-related issues

  • Call Centre 19999


Other Warnings

Warning Date
    2007-08-05

تحذير من إستخدام نبات الصبار كعلاج لمرض السكري

2007-08-05

نشرت بعض وسائل الإعلام خبر اكتشاف باحث يمني فوائد احد انواع نبتة الصبار كعلاج طبيعي لمرض السكري . و توصل الباحث بحسب الدراسة إلى أن الصبار يخفض سكر الدم الغير معتمد على الأنسولين في الأرانب, و بإمكان المرضى المصابين بهذا النوع من سكر الدم الاعتماد على هذا النبات بتناوله مثل أي غذاء آخر.

  • To report sector-related issues

  • Call Centre 19999


Other Warnings

Warning Date
    2007-08-06

Health Canada is advising Canadians not to use the unauthorized smoking cessation product Resolve™

2007-08-06

Health Canada is advising Canadians not to use the unauthorized smoking cessation product Resolve™, because of the potential health risk to consumers.

The product contains an unacceptable amount of an ingredient labelled as "CESTEMENOL-350." Consuming excessive amounts of this ingredient might result in damage to the kidney, liver or red blood cells.

  • To report sector-related issues

  • Call Centre 19999


Other Warnings

Warning Date
    2007-08-07

Oral Anticoagulant and Antiplatelet Therapy and Peripheral Arterial Disease

2007-08-07

Atherosclerotic peripheral arterial disease is associated with an increased risk of myocardial infarction, stroke, and death from cardiovascular causes. Antiplatelet drugs reduce this risk, but the role of oral anticoagulant agents in the prevention of cardiovascular complications in patients with peripheral arterial disease is unclear.

  • To report sector-related issues

  • Call Centre 19999


Other Warnings

Warning Date
    2007-08-13

FDA Warns Consumers in USA to Avoid Red Yeast Rice Products Promoted on Internet as Treatments for High Cholesterol

2007-08-13

The U.S. Food and Drug Administration is warning consumers in USA not to buy or eat three red yeast rice products promoted and sold on Web sites. The products may contain an unauthorized drug that could be harmful to health. The products are promoted as dietary supplements for treating high cholesterol.

  • To report sector-related issues

  • Call Centre 19999


Other Warnings

Warning Date
    2007-08-18

Risk of Serious Adverse Drug Events Associated with the Use of Botulinum Toxin Products (Botox)

2007-08-18

The Medicines and Healthcare products Regulatory Agency (MHRA), the British equivalent of the Saudi Food and Drug Authority (SFDA), announced that reports have been received of serious adverse drug reactions, including deaths, associated with the use of botulinum toxin products. Botox is the only brand name product registered by the Ministry of Health in Saudi Arabia.

  • To report sector-related issues

  • Call Centre 19999


Other Warnings

Warning Date
    2007-08-19

Stronger Heart Failure Risk Warnings for the Diabetes Drugs Rosiglitazone (Avandia) and Pioglitazone (Actos)

2007-08-19

The American Food and Drug Administration (FDA), the U.S. equivalent to the Saudi Food & Drug Authority(SFDA), that the manufacturers of the drugs rosiglitazone (Avandia) and pioglitazone (Actos) will revise the prescribing information for these drugs to include stronger warnings about the risk of congestive heart failure when these drug are used to treat type-2 diabetes.

  • To report sector-related issues

  • Call Centre 19999


Other Warnings

Warning Date
    2007-08-20

Possible Life-Threatening Adverse Effects in Babies of Nursing Mothers Prescribed the Painkiller Codeine

2007-08-20

The U.S. equivalent of the Saudi Food and Drug Authority (SFDA) announced important new information about serious, potentially life-threatening adverse drug effects in nursing infants whose mothers are taking the common painkiller and cough suppressant codeine. A list of some codeine containing products available in The Kingdom accompanies this alert.

  • To report sector-related issues

  • Call Centre 19999


Other Warnings

Subscribe to Drugs